Azenta realigns into three segments and provides historical recast data

Azenta, Inc.

Effective Oct 1, 2023, Azenta restructured into Multiomics, Sample Management Solutions, and B Medical Systems.
Multiomics offers genomic analysis, gene sequencing, and gene synthesis under a single business unit.
Sample Management Solutions combines Sample & Repository, Ultracold Systems, and Consumables & Instruments.
Historical segment data for FY2023 and FY2022 recast to reflect the new structure are provided in Exhibit 99.1.
No specific financial numbers are available in the filing text; recast data requires review of the exhibit.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.